» Articles » PMID: 33999346

Circulating Tumor DNA As a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2021 May 17
PMID 33999346
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring.

Mannucci A, Goel A Mol Cancer. 2024; 23(1):259.

PMID: 39558327 PMC: 11575410. DOI: 10.1186/s12943-024-02174-w.


Potential value of detection of minimal residual disease in colorectal cancer following radical resection.

Pu W, Chen F, Tang Y, Qu Y, Han Y, Zha J Chin J Cancer Res. 2024; 36(4):442-454.

PMID: 39246709 PMC: 11377885. DOI: 10.21147/j.issn.1000-9604.2024.04.07.


Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study).

Kataoka K, Yamada T, Yamazaki K, Mori K, Matsuhashi N, Shiozawa M J Anus Rectum Colon. 2024; 8(3):246-252.

PMID: 39086881 PMC: 11286365. DOI: 10.23922/jarc.2024-025.


Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.

Chen L, Wang Y, Cai C, Ding Y, Kim R, Lipchik C J Clin Oncol. 2024; 42(13):1520-1530.

PMID: 38315963 PMC: 11095904. DOI: 10.1200/JCO.23.01080.


Practical recommendations for using ctDNA in clinical decision making.

Cohen S, Liu M, Aleshin A Nature. 2023; 619(7969):259-268.

PMID: 37438589 DOI: 10.1038/s41586-023-06225-y.